Graham Mazereeuw
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Association Between Endothelial Function and Cognitive Performance in Patients With Coronary Artery Disease During Cardiac Rehabilitation.
Journal: Psychosomatic medicine
Published: November 02, 2018
Novel Phospholipid Signature of Depressive Symptoms in Patients With Coronary Artery Disease.
Journal: Journal of the American Heart Association
Published: May 07, 2018
Availability of naloxone in Canadian pharmacies:a population-based survey.
Journal: CMAJ open
Published: November 10, 2017
Baseline Oxidative Stress Is Associated with Memory Changes in Omega-3 Fatty Acid Treated Coronary Artery Disease Patients.
Journal: Cardiovascular psychiatry and neurology
Published: July 17, 2017
Dr Mazereeuw and Colleagues Reply.
Journal: The Journal of clinical psychiatry
Published: August 26, 2016
Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patients.
Journal: Brain, behavior, and immunity
Published: August 18, 2016
Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial.
Journal: Journal of clinical psychopharmacology
Published: August 17, 2016
A meta-analysis of lipid peroxidation markers in major depression.
Journal: Neuropsychiatric disease and treatment
Published: October 23, 2015
Omega-3/omega-6 fatty acid ratios in different phospholipid classes and depressive symptoms in coronary artery disease patients.
Journal: Brain, behavior, and immunity
Published: September 29, 2015
Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study.
Journal: Neuropsychiatric disease and treatment
Published: September 18, 2015
Last Updated: 09/26/2026